Status:
COMPLETED
Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy
Lead Sponsor:
Ain Shams Maternity Hospital
Conditions:
Iron Deficiency Anemia of Pregnancy
Eligibility:
FEMALE
20-35 years
Phase:
PHASE2
Brief Summary
This study evaluates the efficacy and tolerability of lactoferrin in contrast to ferrous sulphate in the context of iron deficiency anemia with pregnancy. Half of participants will receive lactoferri...
Detailed Description
Lactoferrin and Ferrous sulfate are used to treat iron deficiency anemia in pregnancy. Ferrous sulphate is the most commonly used treatment for iron deficiency anemia. Lactoferrin is a new generatio...
Eligibility Criteria
Inclusion
- Pregnant women with single fetus
- Hb count \< 11g/dL
- ferritin level \< 12 ng/dL
- Gestational age (14 - 30 weeks)
Exclusion
- Associated chronic medical disorder (CKD, liver disease, peptic ulcer and chronic blood loss).
- Associated bleeding disorder
- Anaemia requiring blood tranfusion (Hb \< 7g/dL)
- Hypersensitivity to iron preparations
- Haemoglobinopathies (G6PD, thalassemias, sickle cell disease)
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03481790
Start Date
September 1 2017
End Date
March 5 2018
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams Maternity Hospital
Cairo, Egypt